Biodlink

Acquired

Biodlink is a biotech company in Suzhou, China, founded in 2010. It has raised $102.0M across 1 round, most recently a $102.0M Series B in 2018 (est.).

Empowering pharmaceutical innovation, improving quality of life, safeguarding human health

Headquarters
Suzhou
Founded
2010
Business Model
B2B
Total Funding
$102.0M
Last Round
$102.0M Series BJan 2018
Rounds
1
Acquisition Date
Jan 2026

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

BioDlink is a biologics CDMO that provides one-stop services from R&D and process development through clinical trials, regulatory submission, and commercial GMP manufacturing. Based in Suzhou Industrial Park, the company operates a large-scale GMP production base with more than 20,000 L of monoclonal antibody drug substance capacity and integrated ADC platforms covering monoclonal antibodies, drug substance, and drug product. Established in 2010 and listed on the Hong Kong Stock Exchange in November 2019, BioDlink serves global pharmaceutical clients under quality systems aligned with FDA, EMA, and NMPA standards.

Summary

It has raised $102.0M in total across 1 round, most recently a $102.0M Series B round in 2018 (est.). Investors include Chengwei Ventures.

Tech & App Stack

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionJan 2026

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Biodlink on Indexed.vc
<a href="https://indexed.vc/companies/biodlink"><img src="https://indexed.vc/api/badge/company/biodlink" alt="Biodlink on Indexed.vc" width="260" height="76" /></a>